BNP Paribas Financial Markets’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $32.5M | Buy |
|
|||||
|
2025
Q2 | $20.9M | Buy |
|
|||||
|
2025
Q1 | $1.15M | Sell |
|
|||||
|
2024
Q4 | $2.14M | Sell |
|
|||||
|
2024
Q3 | $2.07M | Buy |
|
|||||
|
2024
Q2 | $1.39M | Sell |
|
|||||
|
2024
Q1 | $3.04M | Sell |
|
|||||
|
2023
Q4 | $5.27M | Buy |
|
|||||
|
2023
Q3 | $2.43M | Buy |
|
|||||
|
2023
Q2 | $2.29M | Sell |
|
|||||
|
2023
Q1 | $3.24M | Sell |
|
|||||
|
2022
Q4 | $13.6M | Buy |
|
|||||
|
2022
Q3 | $1.4M | Buy |
|
|||||
|
2022
Q2 | $197K | Buy |
|
|||||
|
2022
Q1 | $97.3K | Sell |
|
|||||
|
2021
Q4 | $210K | Buy |
|
|||||
|
2021
Q3 | $164K | Buy |
|
|||||
|
2021
Q2 | $41.6K | Sell |
|
|||||
|
2021
Q1 | $124K | Buy |
|
|||||
|
2020
Q4 | $106K | Sell |
|
|||||
|
2020
Q3 | $244K | Buy |
|
|||||
|
2020
Q2 | $183K | Sell |
|
|||||
|
2020
Q1 | $383K | Buy |
|
|||||
|
2019
Q4 | $102K | Sell |
|
|||||
|
2019
Q3 | $116K | Buy |
|
|||||
|
2019
Q2 | $102K | Sell |
|
|||||
|
2019
Q1 | $200K | Buy |
|
|||||
|
2018
Q4 | $9.81K | Sell |
|
|||||
|
2018
Q3 | $60.4K | Buy |
|
|||||
|
2018
Q2 | $53.1K | Sell |
|
|||||
|
2018
Q1 | $116K | Buy |
|
|||||
|
2017
Q4 | $78.6K | Buy |
|
|||||
|
2017
Q3 | $17.8K | Sell |
|
|||||
|
2017
Q2 | $6.89K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $5.93K | Sell |
|
|||||
|
2015
Q3 | $32.7K | Buy |
|
|||||
|
2015
Q2 | $16.9K | Buy |
|
|||||
|
2015
Q1 | $3.04K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $12.5K | Buy |
|
|||||
|
2014
Q2 | $1.42K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $2.76K | Sell |
|
|||||
|
2013
Q3 | $69.3K | Sell |
|
|||||
|
2013
Q2 | $75.4K | Buy |
|